Jacobs Solutions Inc. (J) has a new gig, and it's a big one for the pharma supply chain. On Thursday, the company announced that Sanofi (SNY) selected it to provide engineering, procurement, and construction management services for a new insulin manufacturing facility in Frankfurt, Germany.
Jacobs Lands Sanofi Insulin Plant Gig in Germany Ahead of Earnings
Get Sanofi Alerts
Weekly insights + SMS alerts
A Sweet Contract Win
The facility will sit alongside Sanofi's existing insulin manufacturing campus, supporting production of multiple insulin products and strengthening supply reliability. Jacobs will oversee design, procurement, construction management, and commissioning, leveraging existing site infrastructure and advanced manufacturing technologies.
The win adds to Jacobs' growing life sciences portfolio. Earlier this year, Engineering News-Record ranked Jacobs the No. 1 Pharmaceuticals Design Firm. The company also provides EPCM services for FUJIFILM Biotechnologies' $3.2 billion Holly Springs campus.
Airports and Irish Rail, Too
The Sanofi deal isn't the only recent win. On Nov. 17, Jacobs announced a five-year contract with the Metropolitan Washington Airports Authority to support modernization projects at Washington Dulles International Airport and Ronald Reagan Washington National Airport. That agreement covers engineering oversight, project controls, and construction management, with options for extensions.
On Nov. 13, Jacobs and AECOM announced their appointment to Irish Rail's multidisciplinary consultancy framework. Their joint venture also secured the framework's first project, the Limerick–Limerick Junction rail upgrade, covering engineering, design, environmental assessment, and project delivery services.
Earnings on Deck
Jacobs Solutions is scheduled to report earnings on Nov. 23, 2026. Analysts expect earnings per share of $2.13, compared with $1.75 a year earlier, while revenue is projected at $2.56 billion, down from $3.15 billion.
The stock carries a consensus Buy rating, with an average analyst price forecast of $171. Citigroup maintained its Buy rating and raised its price forecast to $188 on Oct. 23. KeyBanc lowered its forecast to $166 while maintaining an Overweight rating on Oct. 15, while Truist Securities cut its forecast to $160 and maintained a Hold rating on Oct. 5.
Chart Check
Jacobs Solutions maintains a bullish technical setup, trading above its key moving averages. The 20-day SMA remains above the 50-day SMA, while an August golden cross—when the 50-day SMA crossed above the 200-day SMA—reinforces the upward trend.
The Relative Strength Index (RSI) stands at 59.32, indicating neutral-to-bullish momentum without overbought conditions. The MACD also remains above its signal line, supporting the positive trend. With no clearly defined support or resistance levels, traders may watch previous swing highs and lows for potential breakouts or reversals.
Jacobs shares have gained 8.40% over the past 12 months, reflecting positive longer-term price performance.
Momentum vs. Fundamentals
Jacobs Solutions' MarketDash Edge scores highlight strong Momentum at 88.26, contrasting with weaker Quality (22.33), Value (19.50), and Growth (8.82) scores. The rankings indicate strong stock price momentum despite weaker fundamental metrics, putting earnings and guidance in focus ahead of the company's upcoming results.
J Price Action: Jacobs Solutions shares closed 0.63% lower at $157.24 on Wednesday, according to market data.
More News

Futures Climb As Wall Street Braces For Anthropic's Mega-IPO: Palo Alto, NetEase, SELLAS In Focus

NVIDIA's Boardroom Drama Meets Blowout Earnings: Is This a Generational Buy?

Anthropic's Blockbuster IPO: Wall Street Loves It, But the Cash Flow Question Looms

Copper's AI Trade Cracks: $50 Billion Wipeout as Futures Plunge, China Pays Record Premiums

Rick Scott Warns US Is 'Barreling Toward' $41 Trillion Debt Limit As Bipartisan Policy Center Flags Early 2027 Breach

Intel Finally Lands an Outside Customer for Its 18A Chips, and Wall Street Notices

Why SentinelOne Stock Is Gaining Thursday: Palo Alto's Blowout Earnings Light a Fire Under Cybersecurity

Trump Tells Stockpiling Americans to Chill: 'Relax, Everything's Good' After Microsoft, Apple and FAA Outages
Get Sanofi Alerts
Real-time alerts on price moves, news, and trading opportunities.
Join 20,000+ investors. No spam, ever.
Featured Articles
View all news
Futures Climb As Wall Street Braces For Anthropic's Mega-IPO: Palo Alto, NetEase, SELLAS In Focus

NVIDIA's Boardroom Drama Meets Blowout Earnings: Is This a Generational Buy?

Anthropic's Blockbuster IPO: Wall Street Loves It, But the Cash Flow Question Looms

Copper's AI Trade Cracks: $50 Billion Wipeout as Futures Plunge, China Pays Record Premiums

Rick Scott Warns US Is 'Barreling Toward' $41 Trillion Debt Limit As Bipartisan Policy Center Flags Early 2027 Breach

Intel Finally Lands an Outside Customer for Its 18A Chips, and Wall Street Notices

Why SentinelOne Stock Is Gaining Thursday: Palo Alto's Blowout Earnings Light a Fire Under Cybersecurity






